Individual-level determinants of breast and cervical cancer screening and early testing in two regionally representative urban Indian populations.

Breast cancer CARRS Cancer screening Cancer stigma Cervical cancer India Psychosocial factors

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 03 04 2024
revised: 27 08 2024
accepted: 02 09 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: epublish

Résumé

Region-specific data on individual factors associated with uptake of breast and cervical cancer screening or early testing in diverse Indian populations are limited. To assess the prevalence and individual determinants of uptake of breast and/or cervical cancer screening or testing among women aged 30-69 years in regionally representative populations of two large Indian cities: New Delhi and Chennai. We conducted an analysis of the cross-sectional data (2016-2017) nested within the Centre for Cardiometabolic Risk Reduction in South Asia cohort, established in 2010-2011 with 12,271 participants (5365 in New Delhi; 6906 in Chennai). Among 3310 women participants, we evaluated the associations of demographic, socioeconomic, lifestyle, medical, psychosocial, and reproductive factors with breast and/or cervical cancer screening or testing using multivariable logistic regression models with results expressed as adjusted odds ratios (OR) and 95% confidence intervals (CI). At any point prior to 2016-2017, 193 women self-reported having undergone evaluations for breast and/or cervical cancer. The reasons for evaluation were 'general examination' or 'physician's advice' (i.e., screening) or 'being symptomatic' (i.e., early testing). The overall prevalence was 5.8% for screening or testing and 2.5% for screening alone. Formal education (OR:1.88; 95% CI:1.12-3.15), high monthly household income (OR:2.27; 95% CI:1.59-3.25) and less 'fear-of-judgement' (OR:1.65; 95% CI:1.05-2.58) were positively associated with screening or testing uptake. When screening uptake was analysed separately, the results were generally similar. Our findings may have important implications for interventions at community-level (e.g., reducing 'fear-of-judgement', increasing awareness to screening programs and early symptoms) and health-system level (e.g., opportunistic screening).

Identifiants

pubmed: 39309700
doi: 10.1016/j.pmedr.2024.102883
pii: S2211-3355(24)00298-5
pmc: PMC11415582
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102883

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Bryan Min Feng Ooi (B)

School of Medicine, Imperial College, London, UK.

Luke Muschialli (L)

Department of Public Health and Primary Care, University of Cambridge, UK.

Dimple Kondal (D)

Centre for Chronic Disease Control, New Delhi, India.

Gloria Andia (G)

London School of Hygiene and Tropical Medicine, UK.

Ivy Ng Ho Tsun (I)

School of Medicine, Imperial College, London, UK.

Helen Ye Rim Huang (HYR)

Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin, Republic of Ireland.

Kavita Singh (K)

Public Health Foundation of India, Gurugram, Haryana, India.
Heidelberg Institute of Global Health, Heidelberg University, Germany.

Aastha Aggarwal (A)

Centre for Chronic Disease Control, New Delhi, India.

Mohammed K Ali (MK)

Hubert Department of Global Health, Emory University, Atlanta, GA, USA.
Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, GA, USA.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA, USA.

Nikhil Tandon (N)

Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India.

K M Venkat Narayan (KMV)

Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, GA, USA.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Viswanathan Mohan (V)

Madras Diabetes Research Foundation (ICMR Center for Advanced Research on Diabetes), Chennai, Tamil Nadu, India.
Dr. Mohan's Diabetes Specialities Centre (IDF Centre of Excellence in Diabetes Care), Gopalapuram, Chennai, Tamil Nadu, India.

Preet K Dhillon (PK)

Centre for Chronic Disease Control, New Delhi, India.
Genentech Inc, South San Francisco, CA, USA.

Theresa W Gillespie (TW)

Department of Hematology and Medical Oncology, Emory University School of Medicine, and Winship Cancer Institute, Atlanta, GA, USA.

D Prabhakaran (D)

Centre for Chronic Disease Control, New Delhi, India.
London School of Hygiene and Tropical Medicine, UK.
Public Health Foundation of India, Gurugram, Haryana, India.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Michael Goodman (M)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Krithiga Shridhar (K)

Centre for Chronic Disease Control, New Delhi, India.
Centre for Health Analytics, Research, and Trends, Trivedi School of Biosciences, Ashoka University, Sonipat, Haryana, India.

Classifications MeSH